Glanbia PLC (GL9) fair value: what the stock is really worth
As of Nov 12, 2026: fair value (intrinsic value) of Glanbia PLC stock €14.38, price €19.90, that is 27.7% below the price, quality 68 out of 100. Rating: overvalued. Calculated from audited financials with 25 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range €9.31 – €24.84 · fair‑value band €10.54 – €17.97 · the €19.90 price screens above the €14.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 12, 2026.
Follow Glanbia in your weekly email
Every Wednesday you see whether Glanbia is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, capsules, tablets, ready-to-eat bars, and ready-to-drink beverage.
Show moreShow less
It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
In addition, the company engages in the financing business; property and land dealing business; property leasing; provision of business services and management solutions; and bioactive solutions.
It offers its products under the Optimum Nutrition, BSN, Isopure, Nutramino, think!, Amazing Grass brands. The company sells its products through specialty retail, online, gym, and food, drug, mass, and club channels. Glanbia plc was founded in 1964 and is headquartered in Kilkenny, Ireland.
Stock analysis
Glanbia PLC (GL9) currently trades at €19.90, while our model-based Fair Value estimate is €14.38, 28% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of €15.98 per share, and 0 of the 25 models we run sit above the €19.90 price.
Bear case: the Economic Profit group reads lowest at €8.23, and 25 of the 25 models stay below the price. Data coverage for this calculation is high.
Scenario range: €10.54 (bear) to €17.97 (bull), the price of €19.90 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 68/100 (solid quality), in the Consumer Defensive sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Glanbia PLC reported revenue of $3.9B in FY2025 versus $4.2B in FY2021, a compound −1.5%/yr. Reported net income was $183M in FY2025, compounding +2.4%/yr from FY2021.
Key figures
Market cap €4.8B Mid · P/E ratio 24.0 · P/S ratio 1.30 · EPS (TTM) €0.8300 · Dividend yield 2.2% · Net margin 5.8% · Return on equity 12.1% · Return on assets (EBIT) 6.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (low confidence).
What moves the price
The last reported earnings sit well below what analysts expect (earnings in transition, for example after write-downs or an earnings dip); whether the stock is cheap or expensive hinges on the expected recovery actually arriving. Read the fair value with that caveat.
The share trades about 20% below its 52-week high and 41% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at 5% fair-value upside, at −28%, GL9 screens richer than that median.
Fair Value models
Bear€10.54Fair Value €14.38Bull€17.97
Price €19.90 · Downside -27.7%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (€0.3336 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+2.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.6%
Start year 2020 (pandemic). Over 10 years: +3.6% a year
Revenue growth 40 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+8.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.9%
Dividend (yield on the price)2.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5.9% vs 2.0%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.3% → 7%
Pace: the 5-year rate starts in 2020 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+8.6%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+4.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in USD, USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +6.0% a year for the price and +2.1% for the forecasts.
News mood ⓘNews mood, the average tone of recent news (58 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Hype
Recent news coverage is unusually upbeat, far more positive than stocks are typically covered.
AI conclusion: Average moat with moderate margins typical for packaged foods marks the business, yet insufficient data and sector norms block clear assessment of firm-specific capabilities.
Main risk: The leadership transition during upgraded growth targets risks gaps in financial oversight that could affect execution across dairy and nutrition operations.
Glanbia is preparing for a leadership transition with the appointment of its current Chief Digital & Transformation Officer as CFO Designate, effective next year. Her background in the Performance Nutrition segment and prior roles at major consumer companies could sharpen focus on digital efficiencies and protein demand trends. At the same time the change raises questions about continuity in financial oversight during a period of upgraded growth targets. Will this bring stronger execution on transformation or expose gaps in traditional dairy and nutrition operations?
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Packaged Foods · 660 stocks
Beats the industry median on 6/15 measures
A mixed picture versus its industry peers.
Valuation
Quality Score68 · Top 25%
Fair Value upside−27.7% · Below median
Profitability
Return on equity (12 months)12.1% · Above median
Return on assets4.6% · Above median
Net margin (12 months)5.8% · Above median
Operating margin (12 months)10.0% · Above median
Growth and dividend
Revenue growth (quarter YoY)7.9% · Above median
Dividend yield (12 months)2.2% · Below median
Balance sheet
Debt / equity0.33× · Above median
Valuation Multiplesvs Packaged Foods median · lower = cheaper
P/E (12 months)24.0× · Pricier than median
P/B2.77× · Priciest 25%
P/S (12 months)1.30× · Pricier than median
Price / free cash flow (fiscal year)18.8× · Pricier than median
EV/EBITDA11.3× · Pricier than median
PEG9.04× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)40· sector 25
PAST (return on equity)48· sector 30
HEALTH (low debt)83· sector 96
DIVIDEND (yield)45· sector 55
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Glanbia PLC Fair Value". https://www.fairvalue-calculator.com/stock/GL9
Frequently asked questions
Is Glanbia PLC (GL9) overvalued or undervalued?
As of Nov 12, 2026, our model estimates a fair value of €14.38 versus a price of €19.90, about 28% lower (overvalued).
What is the fair value of GL9?
Our model-based fair value for Glanbia PLC is €14.38 (as of Nov 12, 2026), built from audited fundamentals. The current price: €19.90.
What is the quality score of GL9?
Glanbia PLC has a Quality Score of 68/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Glanbia PLC (GL9)?
Our model-based price target is the fair value of €14.38 (as of Nov 12, 2026) from 25 valuation models. Cautious scenario €10.54, optimistic scenario €17.97. It is a calculation from audited fundamentals, not an analyst target.
What is the Glanbia PLC stock forecast for 2026?
Our models put fair value at €14.38, about 28% lower versus a price of €19.90 (overvalued). Cautious scenario €10.54, optimistic scenario €17.97. The calculation is refreshed regularly with new filings.
What is the revenue of Glanbia PLC (GL9)?
Glanbia PLC reported trailing-twelve-month revenue of about $4.1B (latest available figure, as of Nov 12, 2026).
Does Glanbia PLC pay a dividend?
Glanbia PLC currently shows a dividend yield of 2.24% relative to its recent price (as of Nov 12, 2026).
How much is the dividend of Glanbia PLC (GL9) and when is the ex-dividend date?
Glanbia PLC pays a dividend of €0.446 per share a year, a dividend yield of 2.2%. The last ex-dividend date was Aug 20, 2026. A dividend has been paid every year since at least 2000. The payout ratio is 65.0% of earnings. Free cash flow covers the dividend 2.38 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Glanbia PLC (GL9)?
For today's price to be fair in a discounted-cash-flow model, Glanbia PLC would have to grow free cash flow by +8.6 % per year for five years (discount rate 9.0 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.6 % per year. As of Nov 12, 2026.
What discount rate (WACC) does the fair value of GL9 use?
Our models discount Glanbia PLC at 9.0 %: a base by market capitalisation (mid), damped by beta 0.51, country premium for Ireland. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Glanbia PLC that is +8.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (9.0 %) and the same formula as our fair value.
How much growth has Glanbia PLC (GL9) delivered so far?
Over the past 5 years revenue at Glanbia PLC grew +0.6 % a year. The price currently implies free-cash-flow growth of +8.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Glanbia PLC (GL9) growing?
The median revenue growth in the sector is +3.6 % a year. That is the yardstick for the growth priced into Glanbia PLC (+8.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Glanbia PLC (GL9)?
The free-cash-flow yield on the price is 5.32 %: that much free cash flow Glanbia PLC produces per unit of market value. When it exceeds the discount rate of our models (9.0 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Glanbia PLC (GL9)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Glanbia PLC it is €14.38 per share (as of Nov 12, 2026), against a price of €19.90. It is the blended result of 25 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Glanbia PLC stock overvalued or undervalued in 2026?
As of Nov 12, 2026, GL9 trades above its calculated fair value: price €19.90, fair value €14.38, a gap of about −28% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of GL9?
No. The price is what the market pays today (€19.90); the fair value is what the company's own numbers justify (€14.38). For Glanbia PLC the two are €5.52 per share apart. That gap is exactly why we show both numbers side by side.
How much is Glanbia PLC worth?
The market values Glanbia PLC at about €4.8B (market capitalisation, as of Nov 12, 2026). Per share that is €19.90; our models calculate a fair value of €14.38 per share.
What do the bullish and bearish scenarios say about GL9?
Our models span a range for Glanbia PLC: cautious scenario €10.54, base €14.38, optimistic €17.97 per share (as of Nov 12, 2026, price €19.90). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of GL9?
Glanbia PLC trades at a price-to-earnings ratio of 24.0 (as of Nov 12, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €14.38 is built from several models across several years. Median P/E at fiscal year-end, 10 fiscal years (2016 to 2025), reported earnings: 22.1. Other multiples: PEG 9.0, P/B 2.8, P/S 1.3, EV/EBITDA 11.3.
What is the PEG ratio of GL9?
The PEG ratio of Glanbia PLC is 9.04 (P/E divided by earnings growth, as of Nov 12, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of Glanbia PLC (GL9)?
Balance-sheet figures for Glanbia PLC (as of Nov 12, 2026): return on equity 12.1%, debt of 0.33 per unit of equity. They feed the Quality Score of 68/100, which measures business quality independently of the share price.
How far is GL9 from its 52-week high?
Glanbia PLC trades at €19.90, about 20% below its 52-week high of €24.84 and 41% above the low of €14.14 (as of Nov 12, 2026). Distance from the high says nothing about value: that is what the fair value of €14.38 is for.
Which stocks are comparable to Glanbia PLC?
From the same area (Consumer Defensive) we also value Nestlé S.A, Danone S.A, Foshan Haitian Flavouring and Food Company, The Kraft Heinz Company, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Glanbia PLC stock attractive at the current price?
The data as of Nov 12, 2026: price €19.90, calculated fair value €14.38 (−28%), Quality Score 68/100, from 25 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of GL9 calculated?
We run Glanbia PLC through 25 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of €14.38 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.3% above its aggregate fair value. Glanbia PLC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Glanbia PLC (GL9)?
The closing price on Nov 12, 2026 was €19.90. Our model-based fair value is €14.38, about 28% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Glanbia PLC right now?
The price sits above even our optimistic bull case (€17.97). The favourable scenario is already priced in. Solid but not exceptional quality (68/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Glanbia PLC (GL9) come from?
Earnings per share at Glanbia PLC grew +7.1 % a year from 2012 to 2023. Broken into its drivers: revenue per share +9.6 %, EBIT margin −3.8 %, tax rate +0.6 %, residual (interest, one-offs) +1.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Glanbia PLC
How large is the market capitalisation of Glanbia PLC (GL9)?
The market capitalisation of Glanbia PLC is €4.8B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Glanbia PLC (GL9)?
The price-to-sales ratio of Glanbia PLC is 1.30 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Glanbia PLC (GL9)?
Earnings per share at Glanbia PLC are €0.8300 (price ÷ EPS = P/E 24.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Glanbia PLC (GL9)?
The dividend yield of Glanbia PLC is 2.2% (payout 53.7%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Glanbia PLC (GL9)?
The net margin of Glanbia PLC is 5.8% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Glanbia PLC (GL9)?
The return on equity (ROE) of Glanbia PLC is 12.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Glanbia PLC (GL9)?
On an EBIT basis the return on assets of Glanbia PLC is 6.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Glanbia PLC (GL9)?
The operating margin of Glanbia PLC is 10.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Glanbia PLC (GL9)?
Revenue at Glanbia PLC is growing +7.9% versus a year earlier (3y avg −13.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Glanbia PLC (GL9)?
Earnings per share at Glanbia PLC are growing +63.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Glanbia PLC (GL9) carry?
The net debt of Glanbia PLC is $526M (fiscal year 2025, ≈ 1.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Glanbia PLC in the live analysis
One click puts Glanbia PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 12, 2026